TY - JOUR
KW - Analgesics, Opioid/therapeutic use/urine
KW - COVID-19
KW - Fentanyl/urine
KW - Humans
KW - Ontario
KW - Opiate Substitution Treatment
KW - opioid epidemic
KW - Opioid-Related Disorders/diagnosis/rehabilitation/urine
KW - Predictive Value of Tests
KW - Substance Abuse Detection
KW - Substance Abuse Treatment Centers
KW - Urinalysis
KW - Fentanyl
KW - opioid agonist treatment
AU - K. A. Morin
AU - S. Acharya
AU - J. K. Eibl
AU - D. C. Marsh
A1 - 
AD - Northern Ontario School of Medicine Sudbury, ON, Canada.; Northern Ontario School of Medicine Sudbury, ON, Canada.; Northern Ontario School of Medicine Sudbury, ON, Canada; Health Sciences North Research Institute, Sudbury, ON, Canada.; Northern Ontario School of Medicine Sudbury, ON, Canada; Canadian Addiction Treatment Centres, Markham, ON, Canada; ICES North, Sudbury, ON, Canada; Health Sciences North Research Institute, Sudbury, ON, Canada. Electronic address: dmarsh@nosm.ca.
BT - The International journal on drug policy
C5 - Education & Workforce; Opioids & Substance Use
DO - 10.1016/j.drugpo.2020.103088
JF - The International journal on drug policy
LA - eng
M1 - Journal Article
PB - . Published by Elsevier B.V
PY - 2021
SN - 1873-4758; 0955-3959; 0955-3959
SP - 103088
T1 - Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada
T2 - The International journal on drug policy
TI - Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada
U1 - Education & Workforce; Opioids & Substance Use
U2 - 33385974
U3 - 10.1016/j.drugpo.2020.103088
VL - 90
VO - 1873-4758; 0955-3959; 0955-3959
Y1 - 2021
Y2 - Apr
ER -